ADOCIA SA

ADOCIA SA

Adocia SA, a clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. The company's proprietary BioChaperone technological platform is designed and developed to enhance the effectiveness and/or safety of therapeutic proteins. Its clinical product pipeline includes insulin formulations, such as BioChaperone Lispro U100 and U200, which are ultra-rapid formulations of insu... lin analog lispro; BioChaperone Combo, a combination of basal insulin glargine and rapid-acting insulin lispro; and BioChaperone Pramlintide Insulin, a prandial combination of human insulin with amylin pramlintide M1Pram. The company's clinical pipeline also includes BioChaperone Glucagon, which is an aqueous formulation of human glucagon for the treatment of hypoglycemia. Its preclinical pipeline includes BioChaperone LisPram), which is a combination of rapid human insulin analogues and Pramlintide; BioChaperone Glargine GLP1 that is a combination of insulin glargine with GLP-1 receptor agonists for the treatment of diabetes; and BioChaperone Glucagon GLP1, which is a combination of glucagon and a GLP-1 receptor agonist for the treatment of obesity. The company has a strategic alliance with Tonghua Dongbao Pharmaceutical Co., Ltd. to develop and commercialize BioChaperone Lispro and BioChaperone Combo in China and other Asian and Middle Eastern territories. Adocia SA was founded in 2005 and is headquartered in Lyon, France.

Adocia Sa_logo

Industry:
Company

Address:
115 Avenue Lacassagne, Lyon, France Zipcode 69003

Country:
United Kingdom

Phone:
33 4 72 61 06 10

Market Cap:
75.92M
Total Revenue:
8.13M
Total Assets:
61.95M
Total Cash:
43.66M

Chairman: Gerard Soula

Website Url:
http://www.adocia.com


Key Executives
Name Title Pay Year Born
Dr. Gรƒยฉrard Soula Co-Founder, Chairman, CEO, Pres and Interim Director of Bus. Devel. & Legal 365,381$ 1945(75 years old)
Mr. Olivier Soula M.B.A., Ph.D. Co-Founder, Deputy GM, VP, Director of R&D and Director 285,580$ 1970(50 years old)
Ms. Valรƒยฉrie Danaguezian CFO and Admin. & Financial Director N/A N/A
Ms. Geraldine Favre Soula HR Devel. Director N/A N/A
Dr. Bertrand Alluis Head of the Analysis Department and Project Mang. N/A N/A
Dr. David Duracher Head of the Pharmaceutical Devel. & Physical Chemistry Departments and Project Mang. N/A N/A
Dr. Richard Charvet Head of Chemistry Department & Project Mang. N/A N/A
Dr. Grรƒยฉgory Meiffren Head of the Biology Department & Project Mang. N/A N/A
Dr. Stanislav Glezer Medical Director & Chief Medical Officer N/A N/A



Financial & Stock
Company's stock symbol is 0QAI.L. Lastest price : 10.88. Total volume :62.00 Click reload if you want to check the lastest price on market!!!


Site Inspections: http://www.adocia.com

  • Host name: cluster023.hosting.ovh.net
  • IP address: 164.132.235.17
  • Location: France
  • Latitude: 48.8582
  • Longitude: 2.3387
  • Timezone: Europe/Paris

Loading ...
Loading ...


More informations about "Adocia Sa" on Search Engine

ADOCIA a biotechnology company dedicated to protein delivery

Adocia.com Next event March 22-25, 2021 BIO-Europe Spring - Europe's largest springtime digital partnering event dedicated to Life ...

Adocia SA (ADOC.PA) - Yahoo Finance

Finance.yahoo.com Adocia SA, a clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases.

Adocia SA (ADOC.PA) - Yahoo Finance

Finance.yahoo.com Adocia SA (ADOC.PA) Paris - Paris Delayed Price.

Adocia SA, ADOC:PAR profile - FT.com

Markets.ft.com Adocia SA, also known as Adocia, is a France-based company engaged in the biotechnology business sector. It specializes in the research and development of biotherapy products used in tissue...

Adocia SA, A89:STU summary - FT.com

Markets.ft.com Adocia SA, also known as Adocia, is a France-based company engaged in the biotechnology business sector. It specializes in the research and development of biotherapy products used in tissue regeneration and for treating chron ic diseases. The Company develops a BioChaperone Platform used for therapeutic protein delivery in regenerative medicine and chronic disease areas, such as wound Healing ...

ADOCIA SA Share Price - ADOC Share Price

Stockopedia.com Adocia SA, also known as Adocia, is a France-based company engaged in the biotechnology business sector. It specializes in the research and development of biotherapy products used in tissue regeneration and for treating chronic diseases.

ADOCIA SA 0QAI Market Stock | London Stock Exchange

Londonstockexchange.com ADOCIA SA 0QAI Overview - Search stock, chart, recent trades, company information, trading information, company news, fundamentals

ADOCIA SA ADOCIA ORD SHS (0QAI.L) stock price, news, quote ...

Sg.finance.yahoo.com Find the latest ADOCIA SA ADOCIA ORD SHS (0QAI.L) stock quote, history, news and other vital information to help you with your stock trading and investing.

Adocia SA reports Q3 results (OTCMKTS:ADOCY) | Seeking Alpha

Seekingalpha.com Adocia SA (OTCPK:ADOCY): Q3 Revenue of โ‚ฌ59K (-66.5% Y/Y).As of September 30, 2020, cash position was โ‚ฌ35.5M vs. โ‚ฌ43.7M as of January 1, 2020.Press Release